Patent ID: 8431702
Filing Date: 2013-04-30
Classification: A61P,C07D

Abstract:
1. A method of facilitating ocular wound healing in a mammal, or of treating a disease or condition selected from macular degeneration, retinal edema, retinal degeneration, idiopathic pulmonary fibrosis, diabetic retinopathy, optic neuropathy, and glaucomatous retinopathy in a mammal in need of such treatment, comprising administering to said mammal a pharmaceutical composition comprising a substituted hydropyrido-quinoline represented by the structural formula: wherein: Y is C or N; X is oxygen, sulfur or NR R B is C R each R each R in combination with at least one additional component selected from the group consisting of one or more emulsifying agent, wetting agent, sweetening agent, flavoring agent, tonicity adjuster, preservative, buffer, anti-oxidant and combinations thereof.